Last week saw two prominent Chinese VC funds – Future Capital and Qiming Venture Partners – raise new US dollar funds. In other news, biotech firm D3 Bio bagged $200 million to expand its product portfolio, while open-source software developer Zilliz closed an investment round of $43 million.
Biotech Startup D3 Bio Raises $200 Million in Series A round
D3…